SynopsisLeupeptin is a naturally occurring protease inhibitor. The global Leupeptin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. Leupeptin is a prote.....
SynopsisCaspase are a family of protease enzymes which play important roles in programmed cell death. The global Caspase Activity Assay Kit market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during th.....
SynopsisPhosphoramidon Disodium is a metallo-endopeptidase inhibitor. The global Phosphoramidon Disodium market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030......
SynopsisNutlin-3 is an antagonist of Mouse Double Minute 2 (MDM2) The global Nutlin-3 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. Nutlin-3 can pass t.....
SynopsisPifithrin-alpha hydrobromide is a p53 protein inhibitor. The global Pifithrin-alpha Hydrobromide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. .....
SynopsisTrichostatin A is a histone deacetylase (HDAC) inhibitor. The global Trichostatin A market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. Trichostatin .....
SynopsisSM-164 is an extremely potent antagonist of XIAP protein The global SM-164 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. SM-164 is a cell-perme.....
SynopsisSepantronium Bromide is an novel small molecule survivin inhibitor. The global Sepantronium Bromide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
SynopsisVorinostat is a histone deacetylases inhibitor. The global Vorinostat market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. Vorinostat can inhibit HDAC.....
SynopsisPanobinostat is a potent and orally active non-selective HDAC inhibitor. The global Panobinostat market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. .....








